QMS Medical Allied Services Inkomsten in het verleden
Verleden criteriumcontroles 2/6
QMS Medical Allied Services's earnings have been declining at an average annual rate of -0.8%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been declining at an average rate of 5.3% per year. QMS Medical Allied Services's return on equity is 11.4%, and it has net margins of 7.1%.
Belangrijke informatie
-0.8%
Groei van de winst
-14.5%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 29.4% |
| Inkomstengroei | -5.3% |
| Rendement op eigen vermogen | 11.4% |
| Nettomarge | 7.1% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
QMS Medical Allied Services Limited (NSE:QMSMEDI) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Sep 19
QMS Medical Allied Services (NSE:QMSMEDI) Has Affirmed Its Dividend Of ₹0.50
Sep 07QMS Medical Allied Services Limited (NSE:QMSMEDI) Shares Fly 28% But Investors Aren't Buying For Growth
Jun 27We Think QMS Medical Allied Services (NSE:QMSMEDI) Can Stay On Top Of Its Debt
Jun 12There's No Escaping QMS Medical Allied Services Limited's (NSE:QMSMEDI) Muted Earnings
Apr 19Opbrengsten en kosten
Hoe QMS Medical Allied Services geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 1,265 | 89 | 61 | 0 |
| 31 Mar 24 | 1,221 | 90 | 68 | 0 |
| 31 Dec 23 | 1,212 | 90 | 70 | 0 |
| 30 Jun 23 | 1,055 | 82 | 40 | 0 |
| 31 Mar 23 | 1,040 | 64 | 55 | 0 |
| 31 Dec 22 | 1,134 | 96 | 30 | 0 |
| 30 Sep 22 | 1,232 | 75 | 52 | 0 |
| 30 Jun 22 | 1,333 | 86 | 52 | 0 |
| 31 Mar 22 | 1,463 | 107 | 47 | 0 |
| 30 Sep 21 | 1,384 | 97 | 35 | 0 |
| 30 Jun 21 | 1,302 | 103 | 32 | 0 |
| 31 Mar 21 | 1,220 | 109 | 28 | 0 |
| 31 Mar 20 | 727 | 64 | 19 | 0 |
| 31 Mar 19 | 519 | 30 | 9 | 0 |
| 31 Mar 18 | 1 | 0 | 0 | 0 |
Kwaliteitswinsten: QMSMEDI has high quality earnings.
Groeiende winstmarge: QMSMEDI's current net profit margins (7.1%) are lower than last year (7.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: QMSMEDI's earnings have declined by 0.8% per year over the past 5 years.
Versnelling van de groei: QMSMEDI's earnings growth over the past year (9.4%) exceeds its 5-year average (-0.8% per year).
Winst versus industrie: QMSMEDI earnings growth over the past year (9.4%) did not outperform the Healthcare industry 30.6%.
Rendement op eigen vermogen
Hoge ROE: QMSMEDI's Return on Equity (11.4%) is considered low.